Catch up on Healio’s top stories on the latest FDA news in ophthalmology.
Topics include the approval of an Eylea biosimilar, clearance of Alcon’s Unity cataract and vitreoretinal cataract systems and more.
FDA approves Vabysmo prefilled syringe for retinal diseases
The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema and retinal vein occlusion. Read more.
FDA approves Eylea biosimilar FYB203/Ahzantive
FYB203/Ahzantive (aflibercept-mrbb) was approved for the treatment of neovascular age-related macular degeneration, diabetic macular edema,